126 related articles for article (PubMed ID: 11309311)
1. Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice.
Moser AR; Hegge LF; Cardiff RD
Cancer Res; 2001 Apr; 61(8):3480-5. PubMed ID: 11309311
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel modifier loci of Apc Min affecting mammary tumor development.
Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR
Cancer Res; 2007 Dec; 67(23):11226-33. PubMed ID: 18056448
[TBL] [Abstract][Full Text] [Related]
3. The ROSA26 LacZ-neo(R) insertion confers resistance to mammary tumors in Apc(Min/+) mice.
Kohlhepp RL; Hegge LF; Moser AR
Mamm Genome; 2001 Aug; 12(8):606-11. PubMed ID: 11471054
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice.
Shoemaker AR; Luongo C; Moser AR; Marton LJ; Dove WF
Cancer Res; 1997 May; 57(10):1999-2006. PubMed ID: 9157997
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of modifiers of the ApcMin mutation in intestine and mammary gland.
Czarnomska A; Krysiak E; Piskorowska J; Sitarz M; Pysniak K; Pilcík T; Demant P
Cancer Res; 2003 Aug; 63(15):4533-7. PubMed ID: 12907628
[TBL] [Abstract][Full Text] [Related]
6. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias.
Moser AR; Mattes EM; Dove WF; Lindstrom MJ; Haag JD; Gould MN
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8977-81. PubMed ID: 8415640
[TBL] [Abstract][Full Text] [Related]
7. The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.
Koratkar R; Pequignot E; Hauck WW; Siracusa LD
Cancer Res; 2002 Oct; 62(19):5413-7. PubMed ID: 12359746
[TBL] [Abstract][Full Text] [Related]
8. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
[TBL] [Abstract][Full Text] [Related]
9. The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse.
Hulboy DL; Gautam S; Fingleton B; Matrisian LM
Oncol Rep; 2004 Jul; 12(1):13-7. PubMed ID: 15201952
[TBL] [Abstract][Full Text] [Related]
10. X radiation up-regulates the occurrence and the multiplicity of invasive carcinomas in the intestinal tract of Apc(min/+) mice.
Nakayama T; Yamazumi K; Uemura T; Yoshizaki A; Yakata Y; Matsuu-Matsuyama M; Shichijo K; Sekine I
Radiat Res; 2007 Oct; 168(4):433-9. PubMed ID: 17903035
[TBL] [Abstract][Full Text] [Related]
11. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
[TBL] [Abstract][Full Text] [Related]
12. Genetic mapping of Mom5, a novel modifier of Apc(Min)-induced intestinal tumorigenesis.
Oikarinen SI; Cleveland AG; Cork KM; Bynoté KK; Rafter JJ; Gustafsson JA; Mutanen M; Gould KA
Carcinogenesis; 2009 Sep; 30(9):1591-6. PubMed ID: 19574546
[TBL] [Abstract][Full Text] [Related]
13. Heterozygosity for a mutation in Brca1 or Atm does not increase susceptibility to ENU-induced mammary tumors in Apc(Min)/+ mice.
Karabinis ME; Larson D; Barlow C; Wynshaw-Boris A; Moser AR
Carcinogenesis; 2001 Feb; 22(2):343-6. PubMed ID: 11181458
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice.
Rao VP; Poutahidis T; Ge Z; Nambiar PR; Horwitz BH; Fox JG; Erdman SE
Cancer Res; 2006 Jan; 66(1):57-61. PubMed ID: 16397216
[TBL] [Abstract][Full Text] [Related]
15. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation.
Andreassen A; Vikse R; Mikalsen A; Adamovic T; Steffensen IL; Hjertholm H; Levan G; Alexander J
Mutat Res; 2006 Apr; 604(1-2):60-70. PubMed ID: 16574467
[TBL] [Abstract][Full Text] [Related]
16. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice.
Sansom OJ; Stark LA; Dunlop MG; Clarke AR
Cancer Res; 2001 Oct; 61(19):7060-4. PubMed ID: 11585736
[TBL] [Abstract][Full Text] [Related]
17. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
18. ROSA26 mice carry a modifier of Min-induced mammary and intestinal tumor development.
Kohlhepp RL; Hegge LF; Nett JE; Moser AR
Mamm Genome; 2000 Dec; 11(12):1058-62. PubMed ID: 11130972
[TBL] [Abstract][Full Text] [Related]
19. Mammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency.
Bennett LM; McAllister KA; Ward T; Malphurs J; Collins NK; Seely JC; Davis BJ; Wiseman RW
Toxicol Pathol; 2001; 29(1):117-25. PubMed ID: 11215675
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
